The Business Research Company’s report goes into great detail on the macular degeneration treatment market size and growth, macular degeneration treatment market regional analysis, macular degeneration treatment market competitive landscape, and other critical information needed to excel in the macular degeneration treatment industry.

Major players in the macular degeneration treatment market include Novartis AG, Bausch Health Companies Inc, Regenxbio Inc, F Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc, Ophthotech Corporation, StemCells Inc, Pfizer Inc, Santen Pharmaceuticals, Alimera Sciences Inc, Aerie Pharmaceutical Inc, Panoptica, Allergan Inc, Valeant Pharmaceuticals, and Rxi Pharmaceuticals.

TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.

The global macular degeneration treatment market size is expected to grow from $7.55 billion in 2021 to $8.08 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The growth in the market is mainly due to the companies’ resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global macular degeneration treatment market size is expected to reach $10.65 billion in 2026 at a CAGR of 7.15%.

North America will be the largest region in the macular degeneration treatment market in 2021.

The macular degeneration treatment market consists of sales of macular degeneration treatment by entities (organizations, sole traders, and partnerships) that are used to treat macular degeneration eye disease. Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the backside of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). Macular degeneration treatment helps to slow the disease and prevent severe loss of vision.

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market.

Request a Sample of the Global Macular Degeneration Treatment Market Report

The development of advanced therapies is a key trend gaining popularity in the macular degeneration treatment market. Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly within the world of inherited retinal disease.

TBRC’s Global Macular Degeneration Treatment Market Report Is Segmented:

By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

By End-User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

By Route of Administration: Oral, Injectable, Others

By Type: Wet Macular Degeneration, Dry Macular Degeneration

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The Macular Degeneration Treatment Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the macular degeneration treatment market globally and regionally, analyzes and forecasts market size, share, macular degeneration treatment market players, macular degeneration treatment market segments, leading competitor revenues, profiles and market shares.

Here Is A List Of Similar Reports From The Business Research Company:

Ophthalmic Devices Global Market Report 2022

Ophthalmic Medical Lasers Global Market Report 2022

Cataract Surgery Devices And Equipment Global Market Report 2022

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn:  https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter:  https://twitter.com/tbrc_info

Check out our Global Market Model:  https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: